Long-acting β2-agonist use in South African children : letter

Long-acting β2-agonist use in South African children : letter

To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SAJCH : the South African journal of child health 2007-01, Vol.1 (1), p.40
Hauptverfasser: Lewis, Humphrey, Green, Robin J., Ossip, Mervyn
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.
ISSN:1994-3032
1999-7671